Journal for ImmunoTherapy of Cancer (Nov 2020)

812 Urelumab (anti-CD137 agonist) in combination with vaccine and nivolumab treatments is safe and associated with pathologic response as neoadjuvant and adjuvant therapy for resectable pancreatic cancer

  • Hao Wang,
  • Elizabeth Thompson,
  • Lei Zheng,
  • Dung Le,
  • Christopher Wolfgang,
  • Robert Anders,
  • Jin He,
  • Carol Judkins,
  • Jessica Hoare,
  • Rachel Klein,
  • Rose Parkinson,
  • Haihui Cao,
  • Jennifer Durham,
  • Katrina Purtell,
  • Ana De Jesus-Acosta,
  • Amol Narang,
  • Richard Burkhart,
  • William Burns,
  • Daniel Laheru

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0812
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.